Calidi Biotherapeutics (CLDI) Total Current Liabilities (2021 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Total Current Liabilities of $3.9 million for Q4 2025, down 58.56% year-over-year from $9.5 million in Q4 2024, and down 24.22% quarter-over-quarter from $5.2 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Total Current Liabilities (2021 - 2026) Analysis & Trends
Calidi Biotherapeutics' Total Current Liabilities history runs 5 years deep, the most recent figure standing at $3.9 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 58.56% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at $3.9 million (down 58.56% YoY), while the FY2025 annual figure was $3.9 million, down 58.56% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $3.9 million, down from $5.2 million in the prior quarter.
- The five-year high for Total Current Liabilities was $43.0 million in Q4 2022, with the low at $373661.0 in Q2 2022.
- The 5-year median for Total Current Liabilities is $6.6 million (2023), against an average of $8.8 million.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 10359.99% in 2022, then sank 76.2% in 2023.
- Calidi Biotherapeutics' Total Current Liabilities stood at $410985.0 in 2021, then soared by 10359.99% to $43.0 million in 2022, then tumbled by 76.2% to $10.2 million in 2023, then declined by 7.19% to $9.5 million in 2024, then plunged by 58.56% to $3.9 million in 2025.
- Business Quant data shows CLDI's Total Current Liabilities at $3.9 million in Q4 2025, $5.2 million in Q3 2025, and $5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.24 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 9.50 Mn |
| Sep 30, 2024 | 11.58 Mn |
| Jun 30, 2024 | 13.05 Mn |
| Mar 31, 2024 | 14.95 Mn |
| Dec 31, 2023 | 10.23 Mn |
| Sep 30, 2023 | 10.87 Mn |
| Jun 30, 2023 | 8.18 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 42.99 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 373,661.00 |
| Mar 31, 2022 | 386,833.00 |
| Dec 31, 2021 | 410,985.00 |